Table 1 Basic demographics of stroke patients and controls
From: Association between plasma levels of hyaluronic acid and functional outcome in acute stroke patients
|  | Controls (n = 159) | Stroke patients (n = 207) | Stroke subtypes | |
|---|---|---|---|---|
|  |  |  | ICH (n = 43) | IS (n = 163) |
Age (years) | 62.7 ± 7.5 | 64.3 ± 13.8 | 60.1 ± 14.7 | 65.4 ± 13.5* |
Male | 90 (56.6) | 139 (67.1) | 28 (65.1) | 111 (68.1) |
Body mass index (kg/m2) | 25.7 ± 4.1 | 25.4 ± 3.8 | 24.0 ± 3.7 | 25.7 ± 3.8 |
Diabetes mellitus | 77 (48.4) | 77 (37.2) | 10 (23.3) | 67 (41.1)* |
Hypertension | 95 (59.7) | 158 (76.3) | 39 (90.7) | 119 (73.0)* |
Hyperlipidemia | 40 (25.2) | 62 (30.0) | 9 (20.9) | 53 (32.5) |
Medication for: | ||||
Diabetes mellitus | NA | 58 (28.0) | 5 (11.6) | 53 (32.5)* |
Hypertension | NA | 113 (54.6) | 22 (51.1) | 91 (55.8) |
Hyperlipidemia | NA | 28 (13.5) | 3 (7.0) | 25 (15.3) |
HA <48 hours (ng/ml) |  |  | 252.6 ± 188.3 | 211.0 ± 206.9 |
HA 48 to 72 hours (ng/ml) |  |  | 554.0 ± 1127.7 | 287.1 ± 540.7* |